Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $693.02 million. The enterprise value is $1.07 billion.
| Market Cap | 693.02M |
| Enterprise Value | 1.07B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 164.61 million shares outstanding. The number of shares has increased by 2.82% in one year.
| Current Share Class | 164.61M |
| Shares Outstanding | 164.61M |
| Shares Change (YoY) | +2.82% |
| Shares Change (QoQ) | +2.62% |
| Owned by Insiders (%) | 3.25% |
| Owned by Institutions (%) | 84.35% |
| Float | 135.05M |
Valuation Ratios
The trailing PE ratio is 6.82 and the forward PE ratio is 3.73.
| PE Ratio | 6.82 |
| Forward PE | 3.73 |
| PS Ratio | 1.92 |
| Forward PS | 1.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.18 |
| P/OCF Ratio | 6.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.25, with an EV/FCF ratio of 9.54.
| EV / Earnings | 10.47 |
| EV / Sales | 2.96 |
| EV / EBITDA | 5.25 |
| EV / EBIT | 5.30 |
| EV / FCF | 9.54 |
Financial Position
The company has a current ratio of 1.41
| Current Ratio | 1.41 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.89 |
| Debt / FCF | 5.32 |
| Interest Coverage | 5.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 33.15% |
| Return on Invested Capital (ROIC) | 68.22% |
| Return on Capital Employed (ROCE) | 101.90% |
| Weighted Average Cost of Capital (WACC) | 4.46% |
| Revenue Per Employee | $3.62M |
| Profits Per Employee | $1.02M |
| Employee Count | 100 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $69.29 million in taxes.
| Income Tax | 69.29M |
| Effective Tax Rate | 40.41% |
Stock Price Statistics
The stock price has increased by +459.62% in the last 52 weeks. The beta is 0.21, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +459.62% |
| 50-Day Moving Average | 3.91 |
| 200-Day Moving Average | 3.49 |
| Relative Strength Index (RSI) | 53.57 |
| Average Volume (20 Days) | 2,827,472 |
Short Selling Information
The latest short interest is 16.23 million, so 9.86% of the outstanding shares have been sold short.
| Short Interest | 16.23M |
| Short Previous Month | 15.90M |
| Short % of Shares Out | 9.86% |
| Short % of Float | 12.02% |
| Short Ratio (days to cover) | 6.74 |
Income Statement
In the last 12 months, IRWD had revenue of $361.51 million and earned $102.18 million in profits. Earnings per share was $0.62.
| Revenue | 361.51M |
| Gross Profit | 271.87M |
| Operating Income | 202.03M |
| Pretax Income | 171.47M |
| Net Income | 102.18M |
| EBITDA | 203.88M |
| EBIT | 202.03M |
| Earnings Per Share (EPS) | $0.62 |
Balance Sheet
The company has $220.47 million in cash and $597.36 million in debt, with a net cash position of -$376.89 million or -$2.29 per share.
| Cash & Cash Equivalents | 220.47M |
| Total Debt | 597.36M |
| Net Cash | -376.89M |
| Net Cash Per Share | -$2.29 |
| Equity (Book Value) | -217.14M |
| Book Value Per Share | -1.32 |
| Working Capital | 95.99M |
Cash Flow
In the last 12 months, operating cash flow was $112.21 million and capital expenditures -$3,000, giving a free cash flow of $112.21 million.
| Operating Cash Flow | 112.21M |
| Capital Expenditures | -3,000 |
| Depreciation & Amortization | 1.85M |
| Net Borrowing | n/a |
| Free Cash Flow | 112.21M |
| FCF Per Share | $0.68 |
Margins
Gross margin is 75.20%, with operating and profit margins of 55.89% and 28.26%.
| Gross Margin | 75.20% |
| Operating Margin | 55.89% |
| Pretax Margin | 47.43% |
| Profit Margin | 28.26% |
| EBITDA Margin | 56.40% |
| EBIT Margin | 55.89% |
| FCF Margin | 31.04% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.82% |
| Shareholder Yield | -2.82% |
| Earnings Yield | 14.74% |
| FCF Yield | 16.19% |
Analyst Forecast
The average price target for IRWD is $6.10, which is 44.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.10 |
| Price Target Difference | 44.89% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 18.19% |
| EPS Growth Forecast (3Y) | 82.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -2.31 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.31 |
| Piotroski F-Score | 7 |